Answers are grounded in this paper and cite their sources.
Oxybutynin is an anticholinergic drug with an emerging role in the treatment of hyperhidrosis. Several recent studies have documented that it is effective both in focal and generalized hyperhidrosis and shows universally good response among different groups of patients regardless of age, gender, and weight. The most common adverse event is dry mouth reported by almost all patients treated. The way this might affect long-term compliance and tolerability should be better investigated in the future.
No takes yet. Share an insight, caveat, or question.
Campanati et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: